Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and ...

Eli Lilly and Company (NYSE:LLY) is one of Goldman Sachs’s top growth stock picks. On February 18, Eli Lilly and Company (NYSE:LLY) said using Taltz (ixekizumab) together with Zepbound (tirzepatide) ...

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and overweight or obesity, according to topline results announced by Eli ...

Eli Lilly (NYSE:LLY) reported successful results from the TOGETHER-PsO Phase 3b trial combining Taltz and Zepbound for ...

New findings indicate that in adults with moderate-to-severe plaque psoriasis who are overweight or obese, combined treatment with ixekizumab (Taltz) and tirzepatide (Zepbound) results ...

Rep. Justin J. Pearson, local groups oppose xAI's permit for 41 gas turbines ...

The move, formalised by Army Headquarters, comes shortly after Prime Minister Tarique Rahman’s government assumed office on ...

Join our free webinar for a quick tour around ch-aviation with an introduction to its Business Aviation data & news and best practices for a flying start.

Join us as Christopher Pearson gets ready for his next big challenge by warming up with skilled trainer Nate Jones on the pads. In this captivating video, witness the dedication and precision that ...

A charity representing cancer patients has said it expects a ‘move toward resolution’ when it meets the Transport Minister.